Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-011849
Filing Date
2025-02-12
Accepted
2025-02-12 08:02:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7286
  Complete submission text file 0001104659-25-011849.txt   8848
Mailing Address 2609 CALDWELL MILL LN BIRMINGHAM AL 35243
Business Address
SATTERFIELD THOMAS A JR (Filed by) CIK: 0001132317 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Subject) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94604 | Film No.: 25612067
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)